SCHEMBL6953448

SCHEMBL6953448

Cc1cc(C)cc(-c2oc(=O)c(C(Cc3ccccc3)SCc3ccccc3)c(O)c2C)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 1/20 0.34
RXRB P28702 1/20 0.34
RXRG P48443 1/20 0.34
CNR2 P34972 1/20 0.34
GPR55 Q9Y2T6 1/20 0.34
IDO1 P14902 1/20 0.32
NQO1 P15559 2/20 0.32
KDM4E B2RXH2 3/20 0.31
GAA P10253 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
MAPT P10636 2/20 0.31
CYP2C9 P11712 2/20 0.31
CYP2C19 P33261 2/20 0.31
JAK2 O60674 1/20 0.31
POLB P06746 1/20 0.31
PKM P14618 1/20 0.31
MAPK1 P28482 1/20 0.31
MPI P34949 1/20 0.31
HTT P42858 1/20 0.31
BLM P54132 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8945373 0.74 NQO1 (0.55) NQO1KDM4ECYP2C9ADORA3ALDH1A1
SCHEMBL6954004 0.64 SMN1; SMN2 (0.41) KDM4ESMN1; SMN2MAPTCYP2C9CYP2C19
SCHEMBL7385462 0.64 MEN1 (0.32) MAPTL3MBTL1ALDH1A1CYP3A4TSHR
SCHEMBL6963460 0.62 EGFR (0.41) SMN1; SMN2MAPTCYP2C9CYP2C19POLB
SCHEMBL7409285 0.62 ABCB1 (0.39) KDM4ESMN1; SMN2MAPTCYP2C9CYP2C19
SCHEMBL6954754 0.60 SMN1; SMN2 (0.40) KDM4ESMN1; SMN2MAPTCYP2C9CYP2C19
SCHEMBL9038366 0.60 SMN1; SMN2 (0.42) KDM4ESMN1; SMN2MAPTCYP2C9CYP2C19
SCHEMBL6173554 0.60 MAPT (0.47) NQO1GAASMN1; SMN2MAPTCYP2C9
SCHEMBL7367968 0.59 SMN1; SMN2 (0.44) KDM4ESMN1; SMN2MAPTCYP2C9CYP2C19
SCHEMBL6955768 0.59 SMN1; SMN2 (0.44) KDM4ESMN1; SMN2MAPTCYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP claimed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP claimed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO claimed
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed